Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 10 Apr 2026 for Crinetics Pharmaceuticals, Inc., €2.9M. Read the official filing
Filing timeline
BuySaleJeff E. Knight
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jeff E. Knight: trading record in brief
Jeff E. Knight, listed as chief executive, appears in our data through filings on Crinetics Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 28 February 2022 to 8 April 2026, the count stands at 18 filings.
On the market, this insider has only sold: 5 sales, €3.4M in total. The rest of the record consists of 7 share grants and 5 option exercises. 2026 to date brings no purchases and 2 sales.
The record was last updated on 10 April 2026 with an option exercise (€1.0M) in Crinetics Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeff E. Knight
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
85,163 shares@ US$40.1049.3% of flowCommon StockSEC:0001628280-26-024716:3
49,474 shares@ US$23.9817.1% of flowCommon StockSEC:0001628280-26-024716:0
9,624 shares@ US$20.022.8% of flowCommon StockSEC:0001628280-26-024716:1
19,336 shares@ US$19.645.5% of flowCommon StockSEC:0001628280-26-024716:2
5,950 shares@ US$37.113.1% of flowCommon StockSEC:0001628280-26-019503:0
34,000 shares0Common StockSEC:0001628280-26-011723:0
6,801 shares@ US$34.1714.1% of flowCommon StockSEC:0000950170-25-043404:0
43,000 shares0Common StockSEC:0000950170-25-025666:0
501 shares@ US$56.521.8% of flowCommon StockSEC:0000950170-24-131064:0
17,499 shares@ US$23.9825.6% of flowCommon StockSEC:0000950170-24-084346:0
956 shares@ US$44.382.6% of flowCommon StockSEC:0000950170-24-079152:0
30,000 shares@ US$23.9844.0% of flowCommon StockSEC:0001209191-24-005081:0
4,283 shares@ US$38.1410.0% of flowCommon StockSEC:0001209191-24-005012:0
23,000 shares0Common StockSEC:0001209191-24-004606:0
587 shares@ US$17.120.6% of flowCommon StockSEC:0001209191-23-019768:0
29,500 shares0Common StockSEC:0001209191-23-015556:0
1,152 shares@ US$17.441.3% of flowCommon StockSEC:0001209191-22-043524:0
4,950 shares0Common StockSEC:0001209191-22-015133:0
18 of 18 declarations
